Short answer
ArriVent BioPharma, Inc. (AVBP) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 financial results announced for quarter ended September 30, 2026.
ArriVent BioPharma, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 financial results announced for quarter ended September 30, 2026
- Investor-relevant figures and management commentary contained in Exhibit 99.1 press release
Item 5.02 · Departure/Election of Directors or Officers
- Stuart Lutzker, President of R&D and director, retires effective December 1, 2026
- Departure not related to disagreements, reducing apparent governance or operational conflict risk
- One-time retirement payment of $428,438.21, subject to duties, restrictive covenants, and claims release
- Chief Medical Officer Priti Patel assumes R&D leadership December 1, 2026
- Leadership continuity supported by Patel’s oncology, hematology, and clinical-development background
Item EX-99.1 · Exhibit EX-99.1
- FURVENT missed its primary PFS endpoint, weakening firmonertinib’s near-term approval case despite 11.0-month PFS vs 9.5 months and ORR 60% vs 33%
- ALPACCA Phase 3 enrollment remains on track, preserving the lead program’s potential in EGFR PACC-mutant NSCLC
- ARR-217 showed preliminary ORR 44.8% and DCR 93.1% at 6 mg/kg, supporting continued ADC development in colorectal cancer
- Cash and investments $393.2 million, expected to fund operations to mid-2028, reducing near-term financing risk
- Nine-month net loss $133.5 million, with G&A rising to $28.3 million from $17.5 million and R&D at $118.9 million
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ArriVent BioPharma, Inc. 8-K filings
Get the next AVBP 8-K as it lands
Follow AVBP for push alerts, or ask the research agent what this filing means.